• Molecular NamePhentolamine
  • SynonymNA
  • Weight281.359
  • Drugbank_IDDB00692
  • ACS_NO50-60-2
  • Show 3D model
  • LogP (experiment)3.4
  • LogP (predicted, AB/LogP v2.0)3.06
  • pka7.7
  • LogD (pH=7, predicted)0.26
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.17
  • LogSw (predicted, AB/LogsW2.0)0.54
  • Sw (mg/ml) (predicted, ACD/Labs)0.12
  • No.of HBond Donors2
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds4
  • TPSA47.86
  • StatusFDA approved
  • AdministrationIV or IM
  • PharmacologyA reversible nonselective alpha-adrenergic antagonist.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding54.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life19 min following intravenous administration
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityAcute and prolonged hypotensive episodes, tachycardia, and cardiac arrhythmias have been reported. In addition, weakness, dizziness, flushing, orthostatic hypotension, nasal stuffiness, nausea, vomiting, and diarrhea may occur.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A